Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Chronic Lymphocytic Leukemia Treatment in México: Up to Half Patients May Not Requiere Treatment

Luisa Fernanda Sánchez-Valledor, MD, Carmina Alejandra Córdova-Ramírez, Gilberto David Elias-de-la-Cruz, MD, Montserrat Rivera-Álvarez, MD, Antonio Cruz-Mora, MD, Yahveth Cantero-Fortiz, MD, Dina Khalaf, BSc, MSc, MD, Juan Carlos Olivares-Gazca, MD, Andrés A. León-Peña, MD, Iván Murrieta-Álvarez, MD, Guillermo J. Ruiz-Delgado, MD FACP, Guillermo J. Ruiz-Argüelles, FRCP, MACP, DSc(hon)

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-134066

Published: 2020

Journal Articles

Long-Term Results of the Treatment of Persons with Hodgkin's Lymphoma in a Resource-Constrained Setting: Real-World Data from a Single Center

Luisa Fernanda Sánchez-Valledor, MD, Thomas M. Habermann, MD, Iván Murrieta-Álvarez, MD, Andrés A. León-Peña, MD, Yahveth Cantero-Fortiz, MD, Carmina Alejandra Córdova-Ramírez, Montserrat Rivera-Álvarez, MD, Juan Carlos Olivares-Gazca, MD, Guillermo J. Ruiz-Delgado, MD FACP, Guillermo J. Ruiz-Arguelles, FRCP, MACP

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-134062

Published: 2020

Journal Articles

Early Response Predicts Long-Term Improvement or Stabilization of Persons with Multiple Sclerosis Treated with Hematopoietic Stem Cell Transplantation

Iván Murrieta-Álvarez, MD, Montserrat Rivera-Álvarez, MD, Gilberto David Elias-de-la-Cruz, MD, Luisa Fernanda Sánchez-Valledor, MD, Carmina Alejandra Córdova-Ramírez, Yahveth Cantero-Fortiz, MD, Andrés A. León-Peña, MD, Martin Ojeda-Laguna, BSc, José Manuel Priesca-Marin, MD, Guillermo J. Ruiz-Delgado, MD FACP, Guillermo J. Ruiz-Arguelles, FRCP, MACP

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-134056

Published: 2020

Journal Articles

Self-Reported Changes in the Expanded Disability Status Scale (EDSS) Score in Persons with Multiple Sclerosis after Autologous Stem Cell Transplants: Experience with the "Mexican Method"

Guillermo J. Ruiz-Arguelles, FRCP, MACP, Juan Carlos Olivares-Gazca, MD, Iván Murrieta-Álvarez, MD, Jesús Mauricio Olivares-Gazca, MD, Andres Leon-Peña, MD, Yahveth Cantero-Fortiz, MD, Elías Eugenio Gonzalez López, MD, Alejandro Ruiz-Argüelles, MD, Andres Gomez De Leon, MD, David Gomez-Almaguer, MD, Luisa Fernanda Sánchez-Valledor, MD, Yarely Itzayana García-Navarrete, MD, Antonio Cruz-Mora, MD, Guillermo J. Ruiz-Delgado, MD FACP

Blood (2019) 134 (Supplement_1): 2020.

https://doi.org/10.1182/blood-2019-123797

Published: 2019

Journal Articles

Quality of Life in Patients with Multiple Sclerosis after Autologous Hematopoietic Stem Cell Transplantation

Juan Carlos Olivares-Gazca, MD, Iván Murrieta-Álvarez, MD, Jesús Mauricio Olivares-Gazca, MD, Yarely Itzayana García-Navarrete, MD, Yahveth Cantero-Fortiz, MD, Andrés A. León-Peña, MD, Guillermo J. Ruiz-Delgado, MD FACP, Guillermo J. Ruiz-Arguelles, FRCP, MACP

Blood (2019) 134 (Supplement_1): 5708.

https://doi.org/10.1182/blood-2019-129031

Published: 2019

Journal Articles

Treatment of Persons with Multiple Myeloma in Underprivileged Circumstances: Real-World Data of a Prospective Study in a Single Institution

Iván Murrieta-Álvarez, MD, David P. Steensma, MD, Juan Carlos Olivares-Gazca, MD, Jesús Mauricio Olivares-Gazca, MD, Andrés A. León-Peña, MD, Yahveth Cantero-Fortiz, MD, Yarely Itzayana García-Navarrete, MD, Antonio Cruz-Mora, MD, Alejandro Ruiz-Argüelles, MD, Guillermo J. Ruiz-Delgado, MD FACP, Guillermo J. Ruiz-Arguelles, FRCP, MACP

Blood (2019) 134 (Supplement_1): 5707.

https://doi.org/10.1182/blood-2019-128972

Published: 2019

Journal Articles

Modifications to the "Classical" Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: Efficacy and Safety Study of a Less Toxic Approach Which Improves the Neurological Condition. a Mexican Perspective

Guillermo Jose Ruiz-Argüelles, Sr., MDFRCP. (GLASG) MACP, Juan Carlos Olivares Gazca, MD, Ivan Murrieta-Alvarez, MD, David Blumenkron-Marroquin, MD, Elias Eugenio Gonzalez-Lopez, MD, Alejandro Ruiz-Argüelles, MD, Guillermo Jose Ruiz-Delgado, Jr., MD, Andres Gomez De Leon, MD, David Gomez-Almaguer, MD

Blood (2017) 130 (Supplement 1): 3290.

https://doi.org/10.1182/blood.V130.Suppl_1.3290.3290

Published: 2017

NARROW

Chronic Lymphocytic Leukemia Treatment in México: Up to Half Patients May Not Requiere Treatment

Long-Term Results of the Treatment of Persons with Hodgkin's Lymphoma in a Resource-Constrained Setting: Real-World Data from a Single Center

Early Response Predicts Long-Term Improvement or Stabilization of Persons with Multiple Sclerosis Treated with Hematopoietic Stem Cell Transplantation

Self-Reported Changes in the Expanded Disability Status Scale (EDSS) Score in Persons with Multiple Sclerosis after Autologous Stem Cell Transplants: Experience with the "Mexican Method"

Quality of Life in Patients with Multiple Sclerosis after Autologous Hematopoietic Stem Cell Transplantation

Treatment of Persons with Multiple Myeloma in Underprivileged Circumstances: Real-World Data of a Prospective Study in a Single Institution

Modifications to the "Classical" Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: Efficacy and Safety Study of a Less Toxic Approach Which Improves the Neurological Condition. a Mexican Perspective

Email alerts

ASH Publications

American Society of Hematology

Chronic Lymphocytic Leukemia Treatment in México: Up to Half Patients May Not Requiere Treatment

Long-Term Results of the Treatment of Persons with Hodgkin's Lymphoma in a Resource-Constrained Setting: Real-World Data from a Single Center

Early Response Predicts Long-Term Improvement or Stabilization of Persons with Multiple Sclerosis Treated with Hematopoietic Stem Cell Transplantation

Self-Reported Changes in the Expanded Disability Status Scale (EDSS) Score in Persons with Multiple Sclerosis after Autologous Stem Cell Transplants: Experience with the "Mexican Method"

Quality of Life in Patients with Multiple Sclerosis after Autologous Hematopoietic Stem Cell Transplantation

Treatment of Persons with Multiple Myeloma in Underprivileged Circumstances: Real-World Data of a Prospective Study in a Single Institution

Modifications to the "Classical" Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: Efficacy and Safety Study of a Less Toxic Approach Which Improves the Neurological Condition. a Mexican Perspective

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only